Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey J Adam

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Methods in Enzymology|April 1, 2008
A method to generate genetically defined tumors in pigsStacey J Adam, Christopher M Counter
Cell Cycle (Georgetown, Tex.)|May 12, 2006
Genetically engineered human cancer models utilizing mammalian transgene expressionS DiSean Kendall, Stacey J Adam, Christopher M Counter
Cancer Research|November 4, 2005
A network of genetic events sufficient to convert normal human cells to a tumorigenic stateS DiSean Kendall, Corinne M Linardic, Stacey J Adam, et al.
Journal of Clinical and Translational Science|October 31, 2024
The future is now: Using the lessons learned from the ACTIV COVID-19 therapeutics trials to create an inclusive and efficient clinical trials enterpriseStacey J Adam, Sarah E Dunsmore, Lisa H Merck, et al.
Brain Research Bulletin|October 7, 2004
Alpha7 nicotinic acetylcholine receptors targeted by cholinergic developmental neurotoxicants: nicotine and chlorpyrifosTheodore A Slotkin, Matthew C Southard, Stacey J Adam, et al.
Cancer Research|December 3, 2008
Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcomaSarasija Naini, Katherine T Etheridge, Stacey J Adam, et al.
Annals of Internal Medicine|June 28, 2021
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 TherapeuticsLisa LaVange, Stacey J Adam, Judith S Currier, et al.
Current Biology : CB|December 19, 2006
Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cellsKian-Huat Lim, Kevin O'Hayer, Stacey J Adam, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Lymphomas that recur after MYC suppression continue to exhibit oncogene addictionPeter S Choi, Jan van Riggelen, Andrew J Gentles, et al.
Oncotarget|March 19, 2015
p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemiaAlper Yetil, Benedict Anchang, Arvin M Gouw, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Methods in Enzymology|April 1, 2008
A method to generate genetically defined tumors in pigsStacey J Adam, Christopher M Counter
Cell Cycle (Georgetown, Tex.)|May 12, 2006
Genetically engineered human cancer models utilizing mammalian transgene expressionS DiSean Kendall, Stacey J Adam, Christopher M Counter
Cancer Research|November 4, 2005
A network of genetic events sufficient to convert normal human cells to a tumorigenic stateS DiSean Kendall, Corinne M Linardic, Stacey J Adam, et al.
Journal of Clinical and Translational Science|October 31, 2024
The future is now: Using the lessons learned from the ACTIV COVID-19 therapeutics trials to create an inclusive and efficient clinical trials enterpriseStacey J Adam, Sarah E Dunsmore, Lisa H Merck, et al.
Brain Research Bulletin|October 7, 2004
Alpha7 nicotinic acetylcholine receptors targeted by cholinergic developmental neurotoxicants: nicotine and chlorpyrifosTheodore A Slotkin, Matthew C Southard, Stacey J Adam, et al.
Cancer Research|December 3, 2008
Defining the cooperative genetic changes that temporally drive alveolar rhabdomyosarcomaSarasija Naini, Katherine T Etheridge, Stacey J Adam, et al.
Annals of Internal Medicine|June 28, 2021
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 TherapeuticsLisa LaVange, Stacey J Adam, Judith S Currier, et al.
Current Biology : CB|December 19, 2006
Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cellsKian-Huat Lim, Kevin O'Hayer, Stacey J Adam, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Lymphomas that recur after MYC suppression continue to exhibit oncogene addictionPeter S Choi, Jan van Riggelen, Andrew J Gentles, et al.
Oncotarget|March 19, 2015
p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemiaAlper Yetil, Benedict Anchang, Arvin M Gouw, et al.
Pageof 5